Interview with Frederic Dufour, General Manager, Biocodex Russia
You have been at your current position for less than a year, and joined BIOCODEX after having managed the Russian affiliate of Yves Saint Laurent. You have a long history…
Address: 119019, г. Москва, ул. Новый Арбат д. 21,Russia
Tel: +7 (495) 783-26-80
Biocodex is an independent, family-owned French pharmaceutical company founded in 1953 by Michel Hublot and Francois Vallet.
We are present in more than 100 countries of the world through subsidiaries and partner companies.
We specialize in several therapeutic areas, namely:
– gastroenterology;
– neurology and psychiatry;
– pain treatment.
Our mission: to develop and make accessible to doctors and their patients effective and safe products which improve the health and quality of life of patients.
Biocodex in Russia
Biocodex drugs have been present in Russia since 1996.
In July 2008 the Biocodex company opened its representative office in Russia with head office in Moscow and 14 major cities covered.
Since 2009 the company promotes pharmaceuticals of a French ophthalmic company Laboratoires Thea, a European leader in the sphere of ophthalmology.
We specialize in several therapeutic areas, namely:
– gastroenterology;
– neurology and psychiatry;
– pain treatment.
You have been at your current position for less than a year, and joined BIOCODEX after having managed the Russian affiliate of Yves Saint Laurent. You have a long history…
Although Russian authorities received heavy criticism for approving the Sputnik V vaccine prior to the completion of Phase III clinical trials, the jab is increasingly being seen as a viable…
Russia has announced that a domestically developed COVID-19 vaccine has been approved by its health authorities, the first such approval globally. However, with large-scale Phase III trials having not yet…
Below is a selection of top stories in Russian pharma from recent months, ranging from proposed changes in legislation, labelling system updates, priorities set forth by the country’s manufacturing association…
Russia is facing a drug shortage crisis which is having a particular impact on patients with life-threatening conditions. A combination of geopolitical and bureaucratic issues are restricting the flow of…
In the latest twist in the ongoing story of Russian interference in the US presidential elections of 2016, it has emerged that Russian internet trolls and automated bots spread misinformation…
In the United States, Johnson & Johnson has an image of being very close to people. Americans grow up with this company — from baby shampoo, to Tylenol when they…
The U.S. and Russia have a long history of trade, and you have personally been with the American Chamber of Commerce in Russia since 2001. Can you give a brief…
The primary objectives of this association are to promote Russia as a clinical trial destination, optimize the regulatory and legislative environment, and promote the interests of ACTO members. Can you…
You took over this organization just three months ago, having previously headed businesses in industries as diverse as retail, food, and automobiles. What drew you to Alliance Healthcare Russia? Do…
The ARPM was founded in 2002, and you were its director from 2002-2004, before leaving for a post at the Roszdravnadzor. You’ve since rejoined as director since 2007. The organization…
When Focus Reports prepared a report on the French pharmaceutical industry in 2009/10, we found that the head of the main multinational pharmaceutical association had taken a career path quite…
You have said that AstraZeneca intends to be “in Russia for Russia” and the company has recently announced a large-scale investment in this country, financing a $150Mn domestic facility in…
See our Cookie Privacy Policy Here